RA CAPITAL MANAGEMENT, L.P. Q2 2016 Filing
Filed August 15, 2016
Portfolio Value
$722.2B
Holdings
32
Report Date
Q2 2016
Filing Type
13F-HR
All Holdings (32 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | WVEWAVE LIFE SCIENCES LTD | 7,088,651 | $146.7B | 20.31% | |
| 2 | —ACHILLION PHARMACEUTICALS INC | 12,033,220 | $93.9B | 13.00% | |
| 3 | —AXOVANT SCIENCES LTD | 5,000,000 | $64.2B | 8.89% | |
| 4 | —AVEXIS INC | 1,339,382 | $50.9B | 7.05% | |
| 5 | ACRSACLARIS THERAPEUTICS INC | 2,627,719 | $48.5B | 6.72% | |
| 6 | NKTREURNEKTAR THERAPEUTICS | 3,224,854 | $45.9B | 6.35% | |
| 7 | ASNDASCENDIS PHARMA A S | 3,412,857 | $45.3B | 6.27% | |
| 8 | TGTXTG THERAPEUTICS INC | 4,531,714 | $27.5B | 3.80% | |
| 9 | ARDXARDELYX INC | 2,312,243 | $20.2B | 2.79% | |
| 10 | —ZOGENIX INC | 2,451,237 | $19.7B | 2.73% | |
| 11 | —VITAE PHARMACEUTICALS INC | 1,575,000 | $17.0B | 2.35% | |
| 12 | —AIMMUNE THERAPEUTICS INC | 1,292,940 | $14.0B | 1.94% | |
| 13 | —ALCOBRA LTD | 3,032,911 | $13.6B | 1.89% | |
| 14 | —PROTEON THERAPEUTICS INC | 1,626,931 | $13.1B | 1.81% | |
| 15 | —AQUINOX PHARMACEUTICALS INC | 1,691,977 | $11.2B | 1.55% | |
| 16 | —STRONGBRIDGE BIOPHARMA PLC | 2,675,338 | $10.6B | 1.47% | |
| 17 | NTRANATERA INC | 783,520 | $9.5B | 1.31% | |
| 18 | —DIMENSION THERAPEUTICS INC | 1,548,033 | $9.3B | 1.29% | |
| 19 | BCRXBIOCRYST PHARMACEUTICALS | 2,989,795 | $8.5B | 1.18% | |
| 20 | —DICERNA PHARMACEUTICALS INC | 2,428,571 | $7.3B | 1.01% | |
| 21 | GBYSANGAMO BIOSCIENCES INC | 1,165,938 | $6.8B | 0.93% | |
| 22 | —AGILE THERAPEUTICS INC | 853,151 | $6.5B | 0.90% | |
| 23 | —TENAX THERAPEUTICS INC | 2,389,700 | $6.1B | 0.85% | |
| 24 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 291,700 | $5.8B | 0.80% | |
| 25 | ONCBEIGENE LTD | 170,000 | $5.1B | 0.70% | |
| 26 | —CIDARA THERAPEUTICS INC | 410,809 | $4.2B | 0.59% | |
| 27 | —AKARI THERAPEUTICS PLC | 234,240 | $3.2B | 0.44% | |
| 28 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 521,550 | $2.5B | 0.35% | |
| 29 | MRUSMERUS N V | 237,599 | $1.9B | 0.26% | |
| 30 | —ZYNERBA PHARMACEUTICALS INC | 253,468 | $1.7B | 0.24% | |
| 31 | —ARCA BIOPHARMA INC | 562,693 | $1.6B | 0.23% | |
| 32 | —PRONAI THERAPEUTICS INC | 29,719 | $59.0M | 0.01% |